Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
TRC105
Description:
TRC105 is an investigational monoclonal antibody targeting endoglin, studied as a cancer therapy in clinical trials and combination treatments.
Primary topic:
Angiogenesis and VEGF in Cancer (27%)
Related topics:
Angiogenesis and VEGF in Cancer (27%),
Radiopharmaceutical Chemistry and Applications (11%)
OpenAlex ID:
keywords/trc105
Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy
2014
·
Feng Chen
, Hao Hong
, et al.
·
Scientific Reports
·
252
PDF
A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
2012
·
Lee S. Rosen
, Herbert I. Hurwitz
, et al.
·
Clinical Cancer Research
·
175
Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis
2018
·
Madelon Paauwe
, Mark J.A. Schoonderwoerd
, et al.
·
Clinical Cancer Research
·
173
PDF
Endoglin-Targeted Cancer Therapy
2010
·
Ben K. Seon
, Akinao Haba
, et al.
·
Current Drug Delivery
·
136
Positron Emission Tomography Imaging of CD105 Expression with a 64Cu-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA
2011
·
Yin Zhang
, Hao Hong
, et al.
·
PLoS ONE
·
132
PDF
Endoglin: Beyond the Endothelium
2020
·
Mark J.A. Schoonderwoerd
, Marie-Jose T.H. Goumans
, et al.
·
Biomolecules
·
127
PDF
Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
2012
·
Olivier Nolan-Stevaux
, Wendy Zhong
, et al.
·
PLoS ONE
·
116
PDF
Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles
2013
·
Jintang Guo
, Hao Hong
, et al.
·
Biomaterials
·
105
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
2018
·
Manabu Kato
, Veronica R. Placencio-Hickok
, et al.
·
Oncogene
·
102
Novel Preparation Methods of 52Mn for ImmunoPET Imaging
2015
·
Stephen A. Graves
, Reinier Hernandez
, et al.
·
Bioconjugate Chemistry
·
99
Endoglin for Targeted Cancer Treatment
2014
·
Lee S. Rosen
, Michael S. Gordon
, et al.
·
Current Oncology Reports
·
92
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
2016
·
M Paauwe
, R C Heijkants
, et al.
·
Oncogene
·
82
PDF
Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105
2011
·
Hao Hong
, Gregory W. Severin
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
82
An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
2018
·
C.R. Mehta
, L. Liu
, et al.
·
Annals of Oncology
·
80
Positron emission tomography imaging of CD105 expression during tumor angiogenesis
2011
·
Hao Hong
, Yunan Yang
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
79
Endoglin interacts with VEGFR2 to promote angiogenesis
2018
·
Hongyu Tian
, Jennifer J. Huang
, et al.
·
The FASEB Journal
·
75
An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer
2014
·
Michael S. Gordon
, Francisco Robert
, et al.
·
Clinical Cancer Research
·
72
Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and a Monoclonal Antibody Dual-Labeled with 89Zr and IRDye 800CW
2012
·
Hao Hong
, Yin Zhang
, et al.
·
Molecular Pharmaceutics
·
72
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells
2019
·
Hong-Wei Wu
, Michael A. Sheard
, et al.
·
Clinical Cancer Research
·
67
Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging
2017
·
Yonghua Zhan
, Sixiang Shi
, et al.
·
ACS Applied Materials & Interfaces
·
63
A phase I study of TRC 105 anti‐endoglin ( CD 105) antibody in metastatic castration‐resistant prostate cancer
2014
·
Fatima H. Karzai
, Andrea B. Apolo
, et al.
·
British Journal of Urology
·
61
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial
2022
·
Robin L. Jones
, Vinod Ravi
, et al.
·
JAMA Oncology
·
57
PDF
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma
2016
·
Andrea B. Apolo
, Fatima H. Karzai
, et al.
·
Clinical Genitourinary Cancer
·
57
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy
2020
·
Mark J.A. Schoonderwoerd
, Maaike F.M. Koops
, et al.
·
Clinical Cancer Research
·
53
PDF
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
2014
·
Yingmiao Liu
, Hongyu Tian
, et al.
·
Investigational New Drugs
·
50
PDF
Show more works
View as search
Works count:
173
Citation count:
3,433
Year
Topic
Type